ATAZANAVIR

Product NDC
59762-0408
11-digit product format
597620408
Labeler code
59762
Product ID
59762-0408_31600e95-44e5-45da-bec8-ae4f596409fb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ATAZANAVIR
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Labeler
Greenstone LLC
Application
NDA021567
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2018-01-02
Marketing end
0000-00-00
Substance
ATAZANAVIR SULFATE
Active strength
150 mg/1
Pharmacologic classes
HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59762-0408-6EA - Each59762-040817fe06d6-e76e-4064-befe-7b60796489ed12018-02-20